EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Frailty and anticoagulants in older subjects with atrial fibrillation: the EUROSAF study

Alberto Pilotto, Nicola Veronese, Maria Cristina Polidori, Timo Strandberg, Eva Topinkova, Alfonso J Cruz-Jentoft, Carlo Custodero iD, Mario Barbagallo, Stefania Maggi, EUROSAF Study Investigators

Age and Ageing · 02.11.2023 · 52 (11)

DOI: 10.1093/ageing/afad216 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Age and Ageing, online erschienen am 27.11.2023. Verfasst von Alberto Pilotto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Geriatrics Unit, Department of Geriatric Care, OrthoGeriatrics and Rehabilitation, E.O. Galliera Hospital, Genova, Italy. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Frail Elderly, Geriatric Assessment. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Geriatric Medicine Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Literature regarding anticoagulants in older people affected by atrial fibrillation (AF) is limited to retrospective studies, poorly considering the importance of multidimensional frailty. The main objective of this study is to evaluate in hospitalised older persons with AF the benefit/risk ratio of the anticoagulant treatments, considering the severity of frailty, determined by the multidimensional prognostic index (MPI).

Methods

In this European, multicentre, prospective study, older hospitalised patients (≥65 years) with non-valvular AF were followed-up for 12 months. Anticoagulants’ use at discharge ascertained using medical records. MPI was calculated using tools derived from comprehensive geriatric assessment, classifying participants in robust, pre-frail or frail. Mortality (primary outcome); vascular events, including ischemic heart disease or ischemic stroke, hemorrhagic stroke or gastrointestinal bleedings (secondary outcomes).

Results

2,022 participants (mean age 82.9 years; females 56.6%) were included. Compared with people not taking anticoagulants (n = 823), people using vitamin K antagonists (n = 450) showed a decreased risk of mortality (hazard ratio, HR = 0.74; 95% CI: 0.59–0.93), more pronounced in patients using direct oral anticoagulants (DOACs) (n = 749) (HR = 0.46; 95% CI: 0.37–0.57). Only people taking DOACs reported a significantly lower risk of vascular events (HR = 0.55; 95% CI: 0.31–0.97). The efficacy of DOACs was present independently from frailty status. The risk of gastrointestinal bleedings and hemorrhagic stroke did not differ based on the anticoagulant treatments and by MPI values.

Conclusions

Anticoagulant treatment, particularly with DOACs, was associated with reduced mortality in older people, without increasing the risk of hemorrhagic events, overall suggesting the importance of treating with anticoagulants older people with AF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAnticoagulantsFrail ElderlyGeriatric AssessmentFrailtyHumansFemaleMaleAged, 80 and overAgedProspective StudiesRisk AssessmentRisk FactorsEurope

Stichwörter der Autor:innen

atrial fibrillationfrailtymortalitymultidimensional prognostic indexolder peoplestroke

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Geriatrics Unit, Department of Geriatric Care, OrthoGeriatrics and Rehabilitation, E.O. Galliera Hospital, Genova, Italy.
  • Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", Bari, Italy.
  • Geriatrics Unit, Department of Internal Medicine, University of Palermo, Palermo, Italy.
  • Ageing Clinical Research, Department II of Internal Medicine and Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • University of Helsinki and Helsinki University Hospital, Helsinki Finland.
  • Center for Life Course Health Research, University of Oulu, Oulu, Finland.

ORCID-Profile: Carlo Custodero

Förderung

  • European Geriatric Medicine Society

Zitieren

APA

Pilotto, A., Veronese, N., Polidori, M. C., Strandberg, T., Topinkova, E., Cruz-Jentoft, A. J., Custodero, C., Barbagallo, M., Maggi, S., & EUROSAF Study Investigators (2023). Frailty and anticoagulants in older subjects with atrial fibrillation: the EUROSAF study. Age and Ageing, 52(11). https://doi.org/10.1093/ageing/afad216

Vancouver

Pilotto A, Veronese N, Polidori MC, Strandberg T, Topinkova E, Cruz-Jentoft AJ, et al. Frailty and anticoagulants in older subjects with atrial fibrillation: the EUROSAF study. Age and Ageing. 2023;52(11). doi:10.1093/ageing/afad216

BibTeX
@article{Pilotto2023,
  author = {Pilotto, Alberto and Veronese, Nicola and Polidori, Maria Cristina and Strandberg, Timo and Topinkova, Eva and Cruz-Jentoft, Alfonso J and Custodero, Carlo and Barbagallo, Mario and Maggi, Stefania and EUROSAF Study Investigators, EUROSAF Study Investigators},
  title = {Frailty and anticoagulants in older subjects with atrial fibrillation: the EUROSAF study},
  journal = {Age and Ageing},
  year = {2023},
  volume = {52},
  number = {11},
  doi = {10.1093/ageing/afad216}
}
Kostenlos starten →